Brain natriuretic peptide: diagnostic and prognostic value in chronic heart failure (a literature review)

被引:0
作者
Sakovych, O. O. [1 ]
Antoniuk, Ya. O. [1 ]
Humeniuk, A. F. [1 ]
Zhebel, V. M. [1 ]
机构
[1] Natl Pirogov Mem Med Univ, Med Fac 2, Dept Internal Med, Vinnytsia, Ukraine
关键词
brain natriuretic peptide; heart failure; diagnosis; prognosis; PRESERVED EJECTION FRACTION; NATIONAL HEART; GUIDED THERAPY; MANAGEMENT; OUTCOMES; ASSOCIATION;
D O I
10.14739/2310-1210.2024.3.297277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increase in the prevalence of cardiovascular disease has caused a rapid increase in the risk of developing heart failure. For many years, chronic heart failure (CHF) has occupied one of the leading positions in the structure of cardiac and all -cause mortality worldwide, resulting in not only negative social, but also economic effects. To optimize the timely detection of this pathological condition, laboratory biomarker-based diagnostics of heart dysfunction is widely used along with echocardiographic examination. Brain natriuretic peptide (BNP) is currently considered one of the most well-known and informative biochemical markers in heart failure. The aim of the work was to cover the results of current scientific research according to the principles of evidence -based medicine regarding the use of BNP and its precursor NT-proBNP for the diagnosis of CHF, prognosis and monitoring of the treatment effectiveness. To achieve this goal, an analysis of literary sources published in scientometric databases such as ScienceDirect, Web of Science, Google Scholar, PubMed, Scopus for the period 2013-2024 was carried out. Conclusions. BNP and NT-proBNP have been found to be informative markers for the early diagnosis of chronic heart failure and can also be recommended for dynamic assessment of patients' condition and the effectiveness of their treatment. It is proposed to continue the research on clarifying the threshold diagnostic levels of the biomarkers in patients with chronic heart failure and comorbid conditions such as type 2 diabetes mellitus, obesity, as well as in consideration of their sex, age, racial and ethnic characteristics, which in the future would promote the optimization of timely diagnosis, selection of appropriate treatment and improvement of further prognosis.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 63 条
  • [1] Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
    Akerblom, Axel
    Wojdyla, Daniel
    Steg, Philippe Gabriel
    Wallentin, Lars
    James, Stefan K.
    Budaj, Andrzej
    Katus, Hugo A.
    Himmelmann, Anders
    Huber, Kurt
    Siegbahn, Agneta
    Storey, Robert F.
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (04) : 563 - 569
  • [2] Heidenreich Paul A, 2022, Circulation, V145, pe895, DOI [10.1161/CIR.0000000000001073, 10.1161/CIR.0000000000001063]
  • [3] The diagnostic value of brain natriuretic peptide in men with comorbid essential arterial hypertension and type 2 diabetes mellitus
    Antoniuk, Ya O.
    Humeniuk, A. F.
    Pashkova, Yu P.
    Sakovych, O. O.
    Zhebel, V. M.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 627 - 636
  • [4] Antoniuk YO, 2020, Biomedical and Biosocial Anthropology, P54, DOI [10.31393/bba38-2020-08, DOI 10.31393/BBA38-2020-08]
  • [5] Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
    Bajaj, Navkaranbir S.
    Gutierrez, Orlando M.
    Arora, Garima
    Judd, Suzanne E.
    Patel, Nirav
    Bennett, Aleena
    Prabhu, Sumanth D.
    Howard, George
    Howard, Virginia J.
    Cushman, Mary
    Arora, Pankaj
    [J]. JAMA CARDIOLOGY, 2018, 3 (01) : 11 - 17
  • [6] Belovol AN, 2017, Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, P4, DOI [10.15407/internalmed2017.01.004, DOI 10.15407/INTERNALMED2017.01.004]
  • [7] Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review
    Berezin, Alexander E.
    Berezin, Alexander A.
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1271 - 1291
  • [8] Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
    Birukov, Anna
    Eichelmann, Fabian
    Kuxhaus, Olga
    Polemiti, Elli
    Fritsche, Andreas
    Wirth, Janine
    Boeing, Heiner
    Weikert, Cornelia
    Schulze, Matthias B.
    [J]. DIABETES CARE, 2020, 43 (12) : 2930 - 2937
  • [9] Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study
    Brutsaert, Erika F.
    Biggs, Mary L.
    Delaney, Joseph A.
    Djousse, Luc
    Gottdiener, John S.
    Ix, Joachim H.
    Kim, Francis
    Mukamal, Kenneth J.
    Siscovick, David S.
    Tracy, Russell P.
    de Boer, Ian H.
    deFilippi, Christopher R.
    Kizer, Jorge R.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (10): : 1489 - 1497
  • [10] Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
    Butler, Javed
    Yang, Mei
    Manzi, Massimiliano Alfonzo
    Hess, Gregory P.
    Patel, Mahesh J.
    Rhodes, Thomas
    Givertz, Michael M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 935 - 944